Ossianix
Latest round
- Seed
Last raised
- May 2013
Total raised
- Undisclosed
Investors
- 1
About Ossianix
Ossianix, Inc.Founded in 2011 and headquartered in Philadelphia, US, Ossianix, Inc. specializes in drug delivery systems, specifically targeting the central nervous system. The company was co-founded by Frank Walsh and Lynn Rutkowski.Ossianix specializes in the development of a unique therapeutic platform focused on the targeted delivery of biologics across the blood-brain barrier (BBB). The company's flagship product, the TXP1 Brain Shuttle, utilizes a deimmunised VNAR antibody scaffold that specifically targets the transferrin receptor 1 (TfR1). This innovative approach enables efficient receptor-mediated transcytosis, allowing for the delivery of therapeutic agents directly into the central nervous system (CNS). The end uses of this technology primarily aim to address neurological disorders, highlighting its potential in advancing the next generation of CNS therapies.Ossianix generates revenue through strategic partnerships and collaborations with pharmaceutical companies seeking to leverage its proprietary technology for drug delivery. The business model is primarily based on B2B transactions, where clients engage Ossianix to integrate the TXP1 Brain Shuttle into their therapeutic pipelines. Revenue structures may include milestone payments contingent upon achieving specific development goals, as well as royalties on future product sales. While specific pricing plans for the TXP1 and associated services are not publicly disclosed, it is anticipated that the company’s offerings are positioned to provide substantial value to partners by enhancing the efficacy of their CNS therapies.Ossianix plans to expand its product offerings, including new iterations of the TXP1 Brain Shuttle, with anticipated launches in the upcoming years. The company is also targeting expansion into the European markets to increase its reach in the pharmaceutical sector.
Who invested in Ossianix
1 investor across 1 round
See all investors in Ossianix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 23, 2013
Amount
Undisclosed
Investors
Questions about Ossianix
Who invested in Ossianix?
Ossianix has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ossianix raised?
Ossianix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ossianix last raise money?
Ossianix's most recent round on record is a Seed, in May 2013.
What does Ossianix do?
Ossianix is a biotechnology company.
Where is Ossianix headquartered?
Ossianix is headquartered in Philadelphia, US.
Which VCs invest in companies like Ossianix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ossianix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ossianix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.